Stock Information
Supernus Pharmaceuticals Inc (SUPN)
Ticker Symbol: SUPN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $2,526.47 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.91
Revenue (TTM): $14.30 M
Dividend Yield: N/A
ROE: -10.42%
Latest News
-
Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?
Mon, Sep 28, 2026 1:41 PM
-
2 Growth Stocks to Add to Your Roster and 1 We Question
Mon, Sep 28, 2026 11:34 AM
-
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
Mon, Sep 28, 2026 5:00 AM
-
Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
Fri, Sep 25, 2026 5:00 AM
Key Financials
Financial data not available
